Cargando…
Development of a New Cell-Based AP-1 Gene Reporter Potency Assay for Anti-Anthrax Toxin Therapeutics
Anthrax toxin is a critical virulence factor of Bacillus anthracis. The toxin comprises protective antigen (PA) and two enzymatic moieties, edema factor (EF) and lethal factor (LF), forming bipartite lethal toxin (LT) and edema toxin (ET). PA binds cellular surface receptors and is required for intr...
Autores principales: | Ouyang, Weiming, Xie, Tao, Fang, Hui, Frucht, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538138/ https://www.ncbi.nlm.nih.gov/pubmed/37755954 http://dx.doi.org/10.3390/toxins15090528 |
Ejemplares similares
-
Development of an in Vitro Potency Assay for Anti-anthrax Lethal Toxin Neutralizing Antibodies
por: Whiting, Gail, et al.
Publicado: (2012) -
A New Murine Model for Gastrointestinal Anthrax Infection
por: Xie, Tao, et al.
Publicado: (2013) -
The Effects of Anthrax Lethal Toxin on Host Barrier Function
por: Xie, Tao, et al.
Publicado: (2011) -
Anthrax Lethal Toxin Disrupts Intestinal Barrier Function and Causes Systemic Infections with Enteric Bacteria
por: Sun, Chen, et al.
Publicado: (2012) -
Latest therapeutic target for gastric cancer: Anthrax toxin receptor 1
por: Sun, Ke-Ran, et al.
Publicado: (2021)